Taxotere, a chemotherapy drug commonly used in cancer treatment, has faced increasing scrutiny for its potential link to eye injuries and vision problems. Patients who have experienced eye damage after being prescribed Taxotere have sought justice through legal avenues to hold the manufacturer accountable for their injuries. 

This article explores the rising phenomenon of seeking justice for eye injuries caused by Taxotere,

What Is Taxotere?

Taxotere is a chemotherapy drug used to treat cancer. It is a type of taxane, which is a group of drugs that work by stopping the growth of cancer cells. Taxotere is typically given as an injection into a vein. 

Taxotere can cause eye injuries by damaging the cornea, which is the clear covering at the front of the eye. This damage can lead to pain, inflammation, and vision problems.

Lawsuit Information Center notes that there is substantial evidence suggesting that Sanofi, the manufacturer of Taxotere, was fully aware of the potential impact of Taxotere could lead to permanent vision impairment. Despite this knowledge, Sanofi failed to provide a clear and adequate warning to both doctors and patients about this risk.

The drug label for Taxotere includes a section called “Post-Marketing Experiences,” which lists various reported incidents or adverse events following the expanded use approval of the drug. One of these events is described as excessive tearing. This could be due to lacrimal duct obstruction, which has been reported.

Additionally, in the Patient Information section of the label, Sanofi acknowledges that “redness of the eye” and “excess tearing” are among “the most common side effects of Taxotere.”

How Does Taxotere Cause Eye Injuries?

During the initial years of Taxotere being available in the market, it was exclusively prescribed to patients with advanced cancer. Unfortunately, only a limited number of these early cancer patients survived long enough to encounter any long-term effects caused by Taxotere. 

As the usage of Taxotere expanded to include cancer patients with significantly higher long-term survival rates, a notable portion of these individuals started facing severe vision issues. 

According to TorHoerman Law, recent research has conclusively demonstrated that Taxotere can lead to epiphora (watery eyes) due to scarring of the lacrimal (tear) system, resulting in irreversible damage to the eyes.

Who is at Risk for Eye Injuries from Taxotere?

Drugwatch notes that lawsuits related to Taxotere claim that the chemotherapy drug has caused eye damage, including cases of vision loss. As of May 2023, there are 197 lawsuits concerning eye damage from the drug in Louisiana federal court. The litigation is still in progress, and thus far, no settlements have been reported.

Anyone who receives Taxotere is at risk for eye injuries. However, some people are more at risk than others, including people who:

  • Have a history of eye problems: People who have had previous eye injuries or who have certain eye conditions, such as dry eye, are more likely to develop eye problems from Taxotere.
  • Are taking other medications that can damage the eyes: Some medications, such as steroids, can increase the risk of eye problems from Taxotere.
  • Are older: Older adults are more likely to develop eye problems from Taxotere.

If you are concerned about your risk of eye problems from Taxotere, talk to your doctor. They can help you assess your risk and determine if you need to take any special precautions.

Symptoms of Eye Injuries from Taxotere

The symptoms of eye injuries from Taxotere include:

  • Pain: The pain from Taxotere eye injuries can be severe and can make it difficult to open your eyes.
  • Redness: The eyes may become red and inflamed.
  • Swelling: The eyelids may swell and become tender.
  • Blurred vision: You may experience blurred vision, difficulty seeing bright light, or double vision.
  • Sensitivity to light: You may be more sensitive to light and find it difficult to be in bright environments.

Legal Options for Victims of Taxotere Eye Injuries

If you have suffered eye injuries from Taxotere, you may have legal options. You may be able to file a Taxotere eye injury lawsuit against the drug manufacturer for negligence. You may also be able to file a lawsuit against your doctor if they failed to properly inform you about the risks of Taxotere.

If you are considering filing a lawsuit, you should contact an attorney who specializes in pharmaceutical liability. An attorney can help you understand your legal rights and options and can represent you in court if necessary.

Taxotere MDL Update

According to, in the Taxotere multidistrict litigation (MDL) process, Judge Milazzo will oversee discovery and pretrial proceedings and is expected to arrange a set of bellwether trials to gauge how juries react to evidence and testimonies concerning the connection between Taxotere and eye damage. 

These bellwether trials are likely to be replicated in numerous cases. If settlements for cases involving watery eyes and excessive tearing are not achieved or the litigation remains unresolved, individual cases may eventually be returned to their respective U.S. District Courts of origin for future trial dates.


The pursuit of justice for eye injuries caused by Taxotere highlights the significance of holding pharmaceutical companies accountable for potential risks associated with their products. As more patients come forward with eye damage and vision problems after using Taxotere, legal actions have been instrumental in seeking compensation from the manufacturer. 

Through legal representation and product liability claims, victims are striving to make their voices heard and shed light on the alleged link between Taxotere and eye injuries.